Raised circulating CK-18 levels, both M30 (caspase-cleaved CK-18) and M65 (full length protein) have been proposed as non-invasive biomarkers for NASH and fibrosis, alone or in composite-biomarkers. Here, KRT18 is linked to metabolic dysfunction-associated steatohepatitis.